Into the Big Leagues
Low dose naltrexone (LDN) is able to do for some people with intractable pain what opioids and other drugs can't do - reduce the pain. Those drugs have something LDN doesn’t, however, – FDA approval.
You can’t prove that LDN works, however, until you can identify Read more [...]
Someone recently commented that because he didn't derive benefits from the Pridgen protocol that it must be snake oil. That would make sense if everyone with fibromyalgia was the same - and could be expected to respond similarly to a treatment but a recent New York Times article "Can a Treatment Read more [...]
A Different Approach
Younger’s been taking a very different approach to chronic fatigue syndrome and fibromyalgia than most researchers and he spoke about it in Pandora's first webinar of the year.
We know that people with ME/CFS and FM regularly leave their doctors appointments with disappointingly Read more [...]
“… No matter what our story, we’re all in the same boat, handling upriver, against the swift current of our thinking.” - Donna Jackson Nakazawa
In 2001 Donna Jackson Nakazawa - a journalist and mother - was paralyzed in a sudden onset of Guillain-Barré Syndrome, an autoimmune disease similar Read more [...]
Ground Zero for Immune Findings
Natural killer (NK) cells are kind of ground zero with regards to immune functioning in chronic fatigue syndrome (ME/CFS). Problems with the ability of NK cells to kill pathogens were identified as early as 1987 and those findings have largely stood the test of Read more [...]
Wrong Name - Real Illness
"... for the scientists and clinicians in the field, the phenomenon (chronic fatigue syndrome) is as real as diabetes or atherosclerosis" - Miriam Tucker
Think physicians aren't interested in chronic fatigue syndrome? They may not be good at treating it and many may Read more [...]
The most important treatment trail in the history of ME/CFS has begun. Take a close look at the huge Rituximab trial that could change how ME/CFS is treated and viewed as Fluge and Mella tell us about it, the many substudies embedded in it and why they think ME/CFS may be an autoimmune disorder in Read more [...]
Mary Dimmock noted that CFSAC, the federal advisory committee on ME/CFS, which is generally not especially noted for it's efficiency, nevertheless responded to the P2P draft report "unprecedented speed, focus and decisiveness" in its special session to respond to the P2P draft report. The committee Read more [...]